StockNews.AISignal intelligence

Signal detail

News insight

Source-backed analysis, the reasoning behind the signal, and its market context.

BLSHBullishEarningsShort Term
High materiality8/10

Bullish reports second quarter 2026 results

StockNews.AIAug 13, 6:45 AM EDT1 source
Trading thesisImportance 8/10

Bullish (BLSH) set for near-term upside on Equiniti close and stronger 2H guidance (6–12 months).

AI summary

What happened and why it matters

Bullish reported Q2 2026 results with improved non-IFRS metrics (Adjusted revenue $92.6M, EBITDA $29.5M) while guiding toward a likely 2026-2027 growth path. The Equiniti acquisition remains on track for a early-2027 close, potentially unlocking full offering capabilities for issuer-sponsored tokens. Regulatory expansion and institutional adoption, via GFSC approval and Morgan Stanley inflows, are key longer-term catalysts.

  • Equiniti deal progress on track; potential value unlock.
  • Morgan Stanley CoinDesk index inflows signal institutional adoption.
  • GFSC tokenized securities approval expands regulated trading footprint.
  • 2H guidance refinement supports near-term valuation rerating.

Sentiment rationale

Despite a quarterly net loss, the company delivered improved non-IFRS metrics (Adjusted EBITDA $29.5M) and refined 2026 guidance. The Equiniti deal progress and regulatory/regional expansions (GFSC) create near-term catalysts for multiple expansion, while Morgan Stanley’s inflows via CoinDesk benchmarks imply broader institutional demand. The near-term price move will hinge on the Equiniti closing timeline and visibility on 2H revenue mix; however, the combination of EBITDA improvement and a defined M&A path supports a bullish bias over 6–12 months.

Key facts

  1. 01

    Q2 2026: Bullish digital asset sales $32.6B; net loss $280M.

  2. 02

    Adjusted revenue $92.6M; Adjusted EBITDA $29.5M.

  3. 03

    Equiniti acquisition on track; close expected early 2027.

  4. 04

    GFSC approves tokenized securities; Morgan Stanley ETFs attract >$400M inflows.

  5. 05

    Guidance refined: 2026 revenue $225–$245M; finance expense $52–$60M.

Earnings

Category: Earnings. The release centers on quarterly metrics and refined full-year guidance, with notable M&A progress (Equiniti) and regulatory/enterprise adoption milestones that could influence multiple valuation drivers for BLSH.